1
|
Arnaud L, Audemard-Verger A, Belot A, Bienvenu B, Burillon C, Chasset F, Chaudot F, Darbon R, Delmotte A, Ebbo M, Espitia O, Fauchais AL, Guedon AF, Hachulla E, Hadjadj J, Hautefort C, Jachiet V, Mamelle E, Martin M, Muraine M, Papo T, Pouchot J, Pugnet G, Seve P, Zenone T, Mekinian A. French protocol for diagnosis and management of Cogan's syndrome. Rev Med Interne 2024:S0248-8663(24)00778-1. [PMID: 39455380 DOI: 10.1016/j.revmed.2024.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Accepted: 09/26/2024] [Indexed: 10/28/2024]
Abstract
Cogan's syndrome is a condition of unknown origin, classified as a systemic vasculitis. It is characterised by a predilection for the cornea and the inner ear. It mainly affects Caucasian individuals with a sex-ratio close to one. Ophthalmological and cochleo-vestibular involvement are the most common manifestations of the disease. The most frequent ophthalmological type of involvement is non-syphilitic interstitial keratitis. Cochleo-vestibular manifestations are similar to those of Meniere's syndrome. The disease progresses in ocular and ear-nose-throat (ENT) flares, which may occur simultaneously or in isolation. Association with other autoimmune diseases, particularly other forms of vasculitis such as polyarteritis nodosa or Takayasu's arteritis, is possible. Ocular involvement, as well as cochleo-vestibular involvement, can be inaugural and initially isolated. Onset is often abrupt. The characteristic involvement is "non-syphilitic" interstitial keratitis. It is usually bilateral from the outset or becomes so during the course of the disease. It presents as a red, painful eye, possibly associated with decreased visual acuity. Cochleo-vestibular involvement is usually bilateral from the outset. It is characterised by the sudden onset of continuous rotational vertigo associated with tinnitus, rapidly progressive sensorineural deafness. Approximately 30-70% of patients present with systemic manifestations. Deterioration in general status with fever may be present. Laboratory evidence of inflammatory syndrome is associated in 75% of cases. Cogan's syndrome is a presumed autoimmune type of vasculitis, although no specific autoantibodies have been identified. Ocular involvement is usually associated with a good prognosis, with total visual acuity recovery in the majority of cases. In contrast, cochleo-vestibular involvement can be severe and irreversible. Therapeutic management of Cogan's syndrome, given its rarity, lacks consensus since no prospective randomised studies have been conducted to date. Corticosteroid therapy is the first-line treatment. Combination with anti-TNF therapy should be promptly discussed.
Collapse
Affiliation(s)
- Laurent Arnaud
- INSERM UMRS-1109, Department of Rheumatology, National Reference Center for Autoimmune diseases (RESO), Strasbourg-Hautepierre University Hospital, Strasbourg, France
| | | | - Alexandre Belot
- Department of Paediatric Nephrology, Rheumatology, Dermatology, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Femme-Mère-Enfant Hospital, Hospices Civils of Lyon, Bron, France
| | - Boris Bienvenu
- Department of Internal Medicine, Saint-Joseph Hospital, Marseille, France
| | - Carole Burillon
- Department of Ophthalmology, Édouard-Herriot University Hospital, Hospices Civils of Lyon, Lyon, France
| | - François Chasset
- Department of Dermatology and Allergology, Tenon Hospital, Faculty of Medicine, Sorbonne University, Paris, France
| | - Florence Chaudot
- Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | | | - Anastasia Delmotte
- Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | - Mikael Ebbo
- Department of Internal Medicine, Marseille University Hospital, Marseille, France
| | - Olivier Espitia
- INSERM UMR1087/CNRS UMR 6291, Team III Vascular & Pulmonary diseases, Department of Internal and Vascular Medicine, institut du thorax, CHU of Nantes, Nantes université, F-44000 Nantes, France
| | - Anne-Laure Fauchais
- Department of Internal Medicine, Dupuytren University Hospital, Limoges, France
| | - Alexis F Guedon
- Department of Internal Medicine, Saint-Antoine Hospital, Paris, France
| | - Eric Hachulla
- INSERM, Department of Internal Medicine and Clinical Immunology, Reference Centre for Auto-immune Systemic Rare Diseases of North and North-West of France (CeRAINO), Lille University Hospital, Lille University, Lille, France
| | - Jérôme Hadjadj
- Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | - Charlotte Hautefort
- Department of Ear, Nose, Throat, Lariboisière Hospital, université Paris Cité, Paris, France
| | - Vincent Jachiet
- Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France
| | | | - Mickael Martin
- Department of Internal Medicine, Poitiers University Hospital, Poitiers, France
| | - Marc Muraine
- Department of Ophthalmology, Rouen University Hospital, Rouen, France
| | - Thomas Papo
- Department of Internal Medicine, Bichat Hospital, Paris, France
| | - Jacques Pouchot
- Department of Internal Medicine, Georges-Pompidou European Hospital, Paris, France
| | - Grégory Pugnet
- Department of Internal Medicine, Toulouse University Hospital, Toulouse, France
| | - Pascal Seve
- Department of Internal Medicine, La Croix-Rousse Hospital, Hospices Civils of Lyon, Lyon, France
| | - Thierry Zenone
- Department of Internal Medicine, Valence Hospital Centre, Valence, France
| | - Arsène Mekinian
- Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
| |
Collapse
|
2
|
Mekinian A, Pouchot J, Zenone T, Fain O. Syndrome de Cogan. Rev Med Interne 2020; 42:269-274. [PMID: 32773166 DOI: 10.1016/j.revmed.2020.07.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 06/23/2020] [Accepted: 07/05/2020] [Indexed: 11/18/2022]
Abstract
"Typical" Cogan's syndrome is defined as a non-syphilitic interstitial keratitis associated with audio-vestibular resembling Ménière's disease with a 2-year maximum delay between these 2 organ impairment. Cogan syndrome is classified as "atypical" in the absence of interstitial keratitis and the presence of other inflammatory eye manifestations, an audio-vestibular impairment different from typical Menière-like disease, or a delay longer than 2 years between eye and audio-vestibular manifestations. Constitutional signs and large-vessel vasculitis is also possible, mostly affecting the thoracic aorta. The presence of acute-phase reactants is common, but no specific laboratory tests are available. The prognosis is dominated by the audio-vestibular impairment and in particular the risk of deafness, while other complications especially vascular complications being rare. Treatment with glucocorticoids is usually necessary and the combination to other immunosuppressive therapies or biological-targeted drugs needs to be determined.
Collapse
Affiliation(s)
- A Mekinian
- Sorbonne Université, AP-HP, Hôpital Saint-Antoine, service de médecine interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), 75012 Paris, France.
| | - J Pouchot
- AP-HP, Université de Paris, Hôpital européen Georges Pompidou, Service de médecine interne, Paris, France
| | - T Zenone
- Service de médecine interne, Hôpital de Valence, Valence, France
| | - O Fain
- Sorbonne Université, AP-HP, Hôpital Saint-Antoine, service de médecine interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), 75012 Paris, France
| |
Collapse
|
3
|
Cotard S, Nouni A, Jaquinandi V, Gladu G, Kaladji A, Mahé G. [Peripheral artery disease in patients younger than 50 years old: Which etiology?]. Ann Cardiol Angeiol (Paris) 2016; 65:275-285. [PMID: 27319272 DOI: 10.1016/j.ancard.2016.04.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Accepted: 04/29/2016] [Indexed: 06/06/2023]
Abstract
Peripheral arterial disease (PAD) encompasses disease of all arteries of the body except the coronary arteries. The main etiology whatever the patient's age is atherosclerosis. Different etiologies can induce PAD especially when patients are younger than 50 years old and have no cardiovascular risk factors (smoking, hypertension, diabetes…). PAD that appears before 50 years old can be named juvenile PAD (JPAD) although there is no consensus about the definition. The aim of this work is to present the different etiologies of JPAD according to their hereditary, acquired or mixed origins. The following hereditary causes are addressed: Marfan syndrome, Ehlers-Danlos syndrome, homocystinuria, pseudoxanthoma elasticum, osteogenesis imperfecta "mid-aortic" syndrome. Among the acquired etiologies, inflammatory JPADs without extravascular signs such as atherosclerosis and Buerger's disease, inflammatory JPADs with extravascular signs as Takayasu's disease, Behçet's disease and Cogan's syndrome, JPADs like aortitis, embolic JPADs, iatrogenic JPADs, and mechanical or traumatic JPADs are described. Finally, mixed origins as thrombotic disease and fibromuscular dysplasia are presented. This work will assist clinicians in the diagnosis of JPAD.
Collapse
Affiliation(s)
- S Cotard
- Imagerie cœur-vaisseaux, centre hospitalier universitaire, hôpital Pontchaillou, 2, rue Henri-Le-Guilloux, 35033 Rennes, France
| | - A Nouni
- Centre hospitalier centre Bretagne, Kério, 56306 Pontivy, France
| | - V Jaquinandi
- Imagerie cœur-vaisseaux, centre hospitalier universitaire, hôpital Pontchaillou, 2, rue Henri-Le-Guilloux, 35033 Rennes, France; Université de Rennes 1, Inserm, centre d'investigation clinique CIC 1414, 35033 Rennes, France
| | - G Gladu
- Clinique du Ter, 56270 Plœmeur, France
| | - A Kaladji
- Service de chirurgie vasculaire, centre hospitalier universitaire, hôpital Pontchaillou, 2, rue Henri-Le-Guilloux, 35033 Rennes, France
| | - G Mahé
- Imagerie cœur-vaisseaux, centre hospitalier universitaire, hôpital Pontchaillou, 2, rue Henri-Le-Guilloux, 35033 Rennes, France; Université de Rennes 1, Inserm, centre d'investigation clinique CIC 1414, 35033 Rennes, France.
| |
Collapse
|